Nonlamellar lyotropic liquid crystalline (LLC) nanoparticles are a family of versatile nano-self-
assemblies, which are finding increasing applications in drug solubilization and targeted …

Onychomycosis continues to be the most challenging disease condition for pharmaceutical
scientists to develop an effective drug delivery system. Treatment challenges lie in …

Antibiotics are essential for treating infections and reducing risks during medical
interventions. However, many commonly used antibiotics lack the physiochemical properties …

Topical drug delivery employing drug nanocarriers has shown prominent results in treating
topical ailments, especially those confined to the skin and eyes. Conventional topical …

Lipid nanoparticles (LNPs) are commonly employed for drug delivery owing to their
considerable drug-loading capacity, low toxicity, and excellent biocompatibility …

Despite having several advantages, bicontinuously structured polymeric nanoparticles
(BSPNPs) are far less explored in the field of controlled drug delivery owing to the …

Amphiphilic lipids are essential biomolecules, critical components in nature's functional
materials, and crucial nutrients in food. Being sustainable, biocompatible, and …

Cubosomes have emerged as a powerful platform for cancer treatment due to their
biocompatibility and ability to encapsulate hydrophilic/lipophilic drugs, providing controlled …

Encapsulating biological and non-biological materials in lipid vesicles presents significant
potential in both industrial and academic settings. When smaller than 100 nm, lipid vesicles …

The clinical translation of photosensitizers based on ruthenium (II) polypyridyl complexes
(RPCs) in photodynamic therapy of cancer faces several challenges. To address these …